Athira Newsroom

JMP Securities Maintains Athira(ATHA.US) With Hold Rating

Futu NewsNov 8 14:31

JMP Securities Keeps Their Hold Rating on Athira Pharma (ATHA)

TipRanksNov 8 13:40

Athira Pharma Analyst Ratings

BenzingaSep 19 18:52

Mizuho Downgrades Athira Pharma to Neutral, Lowers Price Target to $0.5

BenzingaSep 19 18:52

Mizuho Securities Downgrades Athira(ATHA.US) to Hold Rating, Cuts Target Price to $0.5

Futu NewsSep 19 17:32

Jefferies Maintains Athira(ATHA.US) With Hold Rating, Cuts Target Price to $0.5

Futu NewsSep 18 20:33

JMP Securities Maintains Athira(ATHA.US) With Hold Rating

Futu NewsSep 18 02:32

Athira Pharma: A Cautious Hold Amid Strategic Pivot and Clinical Progress

TipRanksSep 18 01:57

Mizuho Securities Maintains Athira(ATHA.US) With Buy Rating, Announces Target Price $5

Futu NewsSep 5 00:32

Athira Pharma Cut to Neutral From Buy by BTIG

Dow JonesSep 4 22:46

Athira Pharma Analyst Ratings

BenzingaSep 4 22:37

Stifel Maintains Athira(ATHA.US) With Hold Rating, Maintains Target Price $4

Futu NewsSep 4 19:33

JMP Securities Downgrades Athira(ATHA.US) to Hold Rating

Futu NewsSep 4 12:32

BTIG Downgrades Athira(ATHA.US) to Hold Rating

Futu NewsSep 4 08:31

BTIG Downgrades Athira Pharma (ATHA) to a Hold

TipRanksSep 4 08:17

Rodman & Renshaw Initiates Athira(ATHA.US) With Buy Rating, Announces Target Price $22

Futu NewsAug 20 19:33

Athira Pharma Analyst Ratings

BenzingaAug 19 22:38

Rodman & Renshaw Initiates Athira Pharma at Buy With $22 Price Target

MT NewswiresAug 19 19:27

JMP Securities Maintains Athira(ATHA.US) With Buy Rating, Maintains Target Price $19

Futu NewsAug 2 13:31

Buy Rating Affirmed for Athira Pharma Amid Positive LIFT-AD Trial Prospects and Expanding Pipeline

TipRanksAug 2 12:57